Increased NPC1L1 and serum cholesterol in a chronic rejection rat

被引:1
|
作者
Zhu, Yanfei [1 ]
Zhou, Jing [2 ]
机构
[1] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gen Surg, Wuxi 214023, Jiangsu Provinc, Peoples R China
[2] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Pathol, Wuxi 214023, Jiangsu Provinc, Peoples R China
来源
CLINICAL AND INVESTIGATIVE MEDICINE | 2011年 / 34卷 / 03期
基金
中国国家自然科学基金;
关键词
CARDIAC TRANSPLANT RECIPIENTS; SMALL-INTESTINE TRANSPLANTATION; ENDOTHELIAL DYSFUNCTION; HYPERCHOLESTEROLEMIA; EZETIMIBE; HYPERLIPIDEMIA; ABSORPTION; ATHEROSCLEROSIS; THERAPY; PROTEIN;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: To measure serum cholesterol and triglyceride levels and NPC1L1 mRNA and protein as an index of cholesterol absorption during the development of chronic rejection (CR) in a rat model of intestinal transplantation. Methods: Rats were randomly divided into two groups: Group 1 (n=20) underwent syngenic Lewis-to-Lewis transplantation and Group 2 (n=20) underwent allogenic F344-to-Lewis transplantation as well as treatment with FK506. Blood samples and intestinal tissue were procured on the 190th day after operation. Histological changes were analyzed and the semiquantitative scores of histological parameters were compared. The serum levels of cholesterol and triglyceride were determined. The expression of Niemann-Pick C1 Like 1(NPC1L1) mRNA and protein were analyzed by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and immunohistochemistry, respectively. Results: All the animals survived for the 190 days. The appearance and histology of isografts were almost normal whereas the allografts displayed thickened bowel wall and mesenteric fibrosis, concentric intimal thickening and interstitial fibrosis and inflammatory in filtration. The histology scores displayed a significant difference between the allografts and isografts (P<0.001). No differences were observed for triglycerides for the two groups. The serum cholesterol levels increased significantly in the allogenic group in comparison with the syngenic group (P=0.034), while no difference was observed for triglyceride levels between groups. RT-PCR showed that the expression of NPC1L1 of allografts increased significantly (P=0.004). Immunohistochemistry confirmed RT-PCR findings. Conclusions: Neointima formation and mesenteric fibrosis were the dominant pathological features. The increased expression of NPC1L1 might contribute to hypercholesterolemia, which may be involved in the pathogenesis of transplant arteriosclerosis.
引用
收藏
页码:E172 / E178
页数:7
相关论文
共 50 条
  • [1] NPC1L1 and cholesterol transport
    Betters, Jenna L.
    Yu, Liqing
    FEBS LETTERS, 2010, 584 (13): : 2740 - 2747
  • [2] NPC1L1 GENE POLYMORPHISMS AFFECTING CHOLESTEROL ABSORPTION
    Maeda, T.
    Numakura, M.
    Mashimo, Y.
    Yoshimura, N.
    Kusano, J.
    Ishikawa, T.
    Murata, K.
    Fujita, M.
    Honda, A.
    Kinoshita, M.
    Matsuzaki, Y.
    Teramoto, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 135 - 135
  • [3] A SNP of NPC1L1 Affects Cholesterol Absorption in Japanese
    Maeda, Tomomi
    Honda, Akira
    Ishikawa, Toshio
    Kinoshita, Makoto
    Mashimo, Yamato
    Takeoka, Yoko
    Yasuda, Daijiro
    Kusano, Jun
    Tsukamoto, Kazuhisa
    Matsuzaki, Yasushi
    Teramoto, Tamio
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (04) : 356 - 360
  • [4] Ezetimibe blocks internalization of the NPC1L1/cholesterol complex
    Chang, Ta-Yuan
    Chang, Catherine
    CELL METABOLISM, 2008, 7 (06) : 469 - 471
  • [5] VITAMIN E TRANSPORT BY A CHOLESTEROL IMPORTER NPC1L1
    Takada, Tappei
    Narushima, Kazuya
    Yamanashi, Yoshihide
    Suzuki, Hiroshi
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 494 - 494
  • [6] INDUCTION OF NPC1L1 MEMBRANE TRANSLOCATION AND CHOLESTEROL ABSORPTION BY CHOLECYSTOKININ
    Yang, H.
    Zhou, L.
    Okoro, E.
    Guo, Z. M.
    ATHEROSCLEROSIS, 2014, 235 (02) : E33 - E33
  • [7] Localization and role of NPC1L1 in cholesterol absorption in human intestine
    Sane, Alain Theophile
    Sinnett, Daniel
    Delvin, Edgard
    Bendayan, Moise
    Marcil, Valerie
    Menard, Daniel
    Beaulieu, Jean-Francois
    Levy, Emile
    JOURNAL OF LIPID RESEARCH, 2006, 47 (10) : 2112 - 2120
  • [8] The role of NPC1L1 in cancer
    Zhang, Renshuai
    Zeng, Jun
    Liu, Wenjing
    Meng, Jingsen
    Wang, Chao
    Shi, Lingyu
    Yang, Shanbo
    Chang, Jing
    Xing, Dongming
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorption
    Pfefferkorn, Jeffrey A.
    Larsen, Scott D.
    Van Huis, Chad
    Sorenson, Roderick
    Barton, Tom
    Winters, Thomas
    Auerbach, Bruce
    Wu, Chenyan
    Wolfram, Thaddeus J.
    Cai, Hongliang
    Welch, Kathleen
    Esmaiel, Nadia
    Davis, JoAnn
    Bousley, Richard
    Olsen, Karl
    Mueller, Sandra Bak
    Mertz, Thomas
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) : 546 - 553
  • [10] Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins
    Saha, Piyali
    Shumate, Justin L.
    Caldwell, Jenna G.
    Elghobashi-Meinhardt, Nadia
    Lu, Albert
    Zhang, Lichao
    Olsson, Niclas E.
    Elias, Joshua E.
    Pfeffer, Suzanne R.
    ELIFE, 2020, 9 : 1 - 28